Vertex Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$3,076,400
$2,964,700
$2,770,200
$2,912,000
Gross Profit
2,661,600
2,557,200
2,407,200
2,488,600
EBITDA
1,356,100
1,338,400
781,800
1,184,400
EBIT
1,302,100
1,286,700
733,400
1,137,900
Net Income
1,082,900
1,032,900
646,300
913,000
Net Change In Cash
3,076,400
2,964,700
2,770,200
2,912,000
Free Cash Flow
1,139,600
927,400
778,200
492,000
Cash
4,939,600
4,972,200
4,674,700
4,569,600
Basic Shares
257,600
258,900
259,500
260,500

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$11,020,100
$9,869,200
$8,930,700
$7,574,400
Gross Profit
9,489,600
8,607,000
7,850,400
6,670,200
EBITDA
486,300
4,605,200
4,435,500
2,917,500
EBIT
280,500
4,423,900
4,287,200
2,791,900
Net Income
-535,600
3,619,600
3,322,000
2,342,100
Net Change In Cash
11,020,100
9,869,200
8,930,700
7,574,400
Cost of Revenue
3,741,100
824,600
Free Cash Flow
-790,300
3,278,900
3,925,200
2,408,500
Cash
4,569,600
10,369,100
10,504,000
6,795,000
Basic Shares
257,900
260,500
259,100
259,899

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$4.80
2025-06-30
$4.52
2025-03-31
$4.06